Literature DB >> 8124143

Systematic underestimation of association between serum cholesterol concentration and ischaemic heart disease in observational studies: data from the BUPA study.

M R Law1, N J Wald, T Wu, A Hackshaw, A Bailey.   

Abstract

OBJECTIVE: To estimate the size of the association between serum concentration of low density lipoprotein cholesterol and mortality from ischaemic heart disease.
DESIGN: Prospective study of total serum cholesterol concentration and mortality from ischaemic heart disease in 21,515 men (538 deaths) and study of total cholesterol concentration measured on two occasions an average of three years apart in 5696 men in whom low density lipoprotein cholesterol concentration was also measured on the second occasion.
SUBJECTS: Men who attended the medical centre of the British United Provident Association (BUPA) in London between 1975 and 1982. MAIN OUTCOME MEASURE: The difference in mortality from ischaemic heart disease for a 0.6 mmol/l difference in concentration of low density lipoprotein cholesterol after adjustment for, firstly, regression dilution bias, which arises from the random fluctuation of serum cholesterol concentration in people over time, and, secondly, the surrogate dilution effect, which arises because differences in total cholesterol concentration between people reflect smaller differences in low density lipoprotein cholesterol concentration.
RESULTS: The observed difference in mortality from ischaemic heart disease associated with a difference of 0.6 mmol/l in total serum cholesterol concentration was 17% but increased to 24% after correction for the regression dilution bias and to 27% (95% confidence interval 21% to 33%) after adjustment for both sources of underestimation, which provides an estimate of the difference in mortality for a true difference of 0.6 mmol/l in low density lipoprotein cholesterol concentration. The association was greater at younger ages. The estimated decrease in mortality from all causes was 6% before and 10% (1% to 17%) after adjustment for the two sources of underestimation. There was no excess mortality from any cause associated with low cholesterol concentration.
CONCLUSIONS: The association between serum cholesterol concentration and ischaemic heart disease is materially stronger than directly inferred from prospective studies. This has important implications for the health benefit of achieving low cholesterol concentrations.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8124143      PMCID: PMC2539480          DOI: 10.1136/bmj.308.6925.363

Source DB:  PubMed          Journal:  BMJ        ISSN: 0959-8138


  17 in total

1.  Calculation of low-density lipoprotein cholesterol with use of triglyceride/cholesterol ratios in lipoproteins compared with other calculation methods.

Authors:  A Rao; A H Parker; N A el-Sheroni; M M Babelly
Journal:  Clin Chem       Date:  1988-12       Impact factor: 8.327

2.  Stability and validity of a single serum cholesterol measurement in a prospective cohort study.

Authors:  S A Törnberg; K F Jakobsson; G A Eklund
Journal:  Int J Epidemiol       Date:  1988-12       Impact factor: 7.196

3.  A single cholesterol measurement underestimates the risk of coronary heart disease. An empirical example from the Lipid Research Clinics Mortality Follow-up Study.

Authors:  C E Davis; B M Rifkind; H Brenner; D J Gordon
Journal:  JAMA       Date:  1990-12-19       Impact factor: 56.272

4.  The variability of serum cholesterol measurements: implications for screening and monitoring.

Authors:  S G Thompson; S J Pocock
Journal:  J Clin Epidemiol       Date:  1990       Impact factor: 6.437

5.  Incidence rates of fatal and nonfatal myocardial infarction in relation to the lipoprotein profile: first prospective results from the Göttingen Risk, Incidence, and Prevalence Study (GRIPS).

Authors:  P Cremer; H Elster; B Labrot; B Kruse; R Muche; D Seidel
Journal:  Klin Wochenschr       Date:  1988

6.  Retest reliability of plasma cholesterol and triglyceride. The Lipid Research Clinics Prevalence Study.

Authors:  D R Jacobs; E Barrett-Connor
Journal:  Am J Epidemiol       Date:  1982-12       Impact factor: 4.897

7.  A comparison of methods for the estimation of plasma low- and very low-density lipoprotein cholesterol. The Lipid Research Clinics Prevalence Study.

Authors:  D M DeLong; E R DeLong; P D Wood; K Lippel; B M Rifkind
Journal:  JAMA       Date:  1986-11-07       Impact factor: 56.272

8.  Comparison of three cholesterol-lowering diets in normolipidemic men.

Authors:  S M Grundy; D Nix; M F Whelan; L Franklin
Journal:  JAMA       Date:  1986-11-07       Impact factor: 56.272

9.  Incidence of coronary heart disease and lipoprotein cholesterol levels. The Framingham Study.

Authors:  W P Castelli; R J Garrison; P W Wilson; R D Abbott; S Kalousdian; W B Kannel
Journal:  JAMA       Date:  1986-11-28       Impact factor: 56.272

10.  Serum cholesterol and subsequent risk of cancer: results from the BUPA study.

Authors:  N J Wald; S G Thompson; M R Law; J W Densem; A Bailey
Journal:  Br J Cancer       Date:  1989-06       Impact factor: 7.640

View more
  64 in total

1.  Joint British recommendations on prevention of coronary heart disease in clinical practice. British Cardiac Society, British Hyperlipidaemia Association, British Hypertension Society, endorsed by the British Diabetic Association.

Authors: 
Journal:  Heart       Date:  1998-12       Impact factor: 5.994

Review 2.  Quantifying effect of statins on low density lipoprotein cholesterol, ischaemic heart disease, and stroke: systematic review and meta-analysis.

Authors:  M R Law; N J Wald; A R Rudnicka
Journal:  BMJ       Date:  2003-06-28

Review 3.  Teleoanalysis: combining data from different types of study.

Authors:  Nicholas J Wald; Joan K Morris
Journal:  BMJ       Date:  2003-09-13

4.  Cholesterol: how low is low enough?

Authors:  A Rosengren
Journal:  BMJ       Date:  1998-08-15

5.  Comparative efficacy and safety of ciprofibrate and sustained-release bezafibrate in patients with type II hyperlipidaemia.

Authors:  D J Betteridge; C G O'Bryan-Tear
Journal:  Postgrad Med J       Date:  1996-12       Impact factor: 2.401

6.  [The distribution of selected cardiac risk factors in employed and studying youths in the rural region of Steiermark (Austria)].

Authors:  E Rásky; W J Stronegger; W Freidl
Journal:  Soz Praventivmed       Date:  1996

7.  Explaining the decrease in coronary heart disease mortality in Italy between 1980 and 2000.

Authors:  Luigi Palmieri; Kathleen Bennett; Simona Giampaoli; Simon Capewell
Journal:  Am J Public Health       Date:  2009-07-16       Impact factor: 9.308

8.  Laboratory-based versus non-laboratory-based method for assessment of cardiovascular disease risk: the NHANES I Follow-up Study cohort.

Authors:  Thomas A Gaziano; Cynthia R Young; Garrett Fitzmaurice; Sidney Atwood; J Michael Gaziano
Journal:  Lancet       Date:  2008-03-15       Impact factor: 79.321

9.  One year sustainability of risk factor change from a 9-week workplace intervention.

Authors:  Elaine C Rush; Michelle B Cumin; Lela Migriauli; Lynnette R Ferguson; Lindsay D Plank
Journal:  J Environ Public Health       Date:  2010-02-10

10.  Lactic acid bacteria affect serum cholesterol levels, harmful fecal enzyme activity, and fecal water content.

Authors:  Do Kyung Lee; Seok Jang; Eun Hye Baek; Mi Jin Kim; Kyung Soon Lee; Hea Soon Shin; Myung Jun Chung; Jin Eung Kim; Kang Oh Lee; Nam Joo Ha
Journal:  Lipids Health Dis       Date:  2009-06-11       Impact factor: 3.876

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.